Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China

Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China

Abstract Background Plasmablastic lymphoma (PBL) is a rare but aggressive B-cell lymphoma subtype with poor prognosis. Knowledge about the etiology, clinicopathologic and molecular features, and outcomes of PBL is limited. This study aimed to examine the clinicopathologic characteristics, therapeuti...

Full description

Bibliographic Details
Main Authors: Di Shi, Lin Gao, Xiao-Chun Wan, Jin Li, Tian Tian, Jue Hu, Qun-Ling Zhang, Yi-Fan Su, Yu-Peng Zeng, Zi-Juan Hu, Bao-Hua Yu, Xiao-Qiu Li, Ping Wei, Ji-Wei Li, Xiao-Yan Zhou
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Medicine
Subjects:
Plasmablastic lymphoma
Immunocompetent
RNA-sequencing
Online Access:https://doi.org/10.1186/s12916-022-02683-9

Internet

https://doi.org/10.1186/s12916-022-02683-9

Similar Items